AstraZeneca Aktie
129,05
EUR
-0,75
EUR
-0,58
%
113,04
GBP
+0,56
GBP
+0,50
%
Werbung
AstraZeneca Aktie Analyse
03.07.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
25.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
24.06.24 | AstraZeneca Overweight | Barclays Capital | |
18.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
10.06.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
05.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
03.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
30.05.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
28.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
22.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
20.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
14.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
07.05.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
29.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
26.04.24 | AstraZeneca Overweight | Barclays Capital | |
25.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
24.04.24 | AstraZeneca Outperform | Bernstein Research | |
23.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
17.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
15.04.24 | AstraZeneca Overweight | Barclays Capital | |
08.04.24 | AstraZeneca Overweight | Barclays Capital | |
05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
04.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
20.02.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
19.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
16.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
12.02.24 | AstraZeneca Overweight | Barclays Capital | |
08.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
30.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.01.24 | AstraZeneca Overweight | Barclays Capital | |
03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
27.12.23 | AstraZeneca Buy | UBS AG | |
12.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
12.12.23 | AstraZeneca Buy | UBS AG | |
05.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
27.11.23 | AstraZeneca Buy | Jefferies & Company Inc. | |
20.11.23 | AstraZeneca Overweight | Barclays Capital | |
17.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
31.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
30.10.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
24.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
23.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
25.09.23 | AstraZeneca Buy | Jefferies & Company Inc. | |
22.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. |
Werbung
Werbung